🇺🇸 GKOS — Glaukos Corporation

Salud Compra fuerte
← Volver

Precio actual

233,04 USD

Máx. histórico

242,48

5 días

Caída desde máximo

-3,89%

Rango 52 semanas

80,91 – 248,75

Variación hoy

-2,33%

Cierre anterior

238,61

Rango de hoy

230,00 – 240,76

Volumen hoy

10.706.919

Peor caída histórica

-69,57%

01/08/2019 → 20/03/2020

Recuperado en 299 días

Volatilidad anualizada ⓘ

54,27%

Información
Nombre completo
Glaukos Corporation
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Medical Devices
Empleados
1.094
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
242,46 USD (puede no estar actualizado)
Primera cotización
25/06/2015
Precio actualizado
hace 21 horas
Sobre la empresa

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor. The company also provides iStent infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. In addition, the company develops iLink, a device used for the treatment of keratoconus without the removal of the epithelium; ILution, a platform of cream-based drug formulation applied to the outer surface of the eyelid for drop less transdermal delivery of pharmaceutically active compounds for the treatment of anterior segment eye disorders; and retinal XR platform to treat age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and other posterior segment retinal diseases. It sells its products to ambulatory surgery centers, hospitals, and physician private practices through a direct sales organization, direct sales subsidiaries, and distributors. The company was formerly known as Transdx, Inc. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
20/01/2017 38,14 38,50 37,76 38,44 +0,81% 1,94% 357.700
19/01/2017 38,87 38,94 37,96 38,13 -1,55% 2,52% 333.200
18/01/2017 39,00 39,26 38,41 38,73 +0,44% 2,18% 267.000
17/01/2017 39,47 39,58 38,30 38,56 -2,33% 3,24% 450.400
13/01/2017 40,06 41,00 39,36 39,48 -1,23% 4,10% 805.300
12/01/2017 38,65 40,06 38,45 39,97 +2,80% 4,17% 650.800
11/01/2017 38,40 39,13 37,28 38,88 +1,75% 4,82% 519.000
10/01/2017 38,50 38,74 37,40 38,21 -0,37% 3,48% 637.900
09/01/2017 36,65 38,95 36,55 38,35 +5,59% 6,55% 1.235.600
06/01/2017 35,62 36,43 34,91 36,32 +8,06% 4,28% 940.200
05/01/2017 34,27 34,45 33,53 33,61 -1,73% 2,68% 264.400
04/01/2017 33,89 34,44 33,18 34,20 +1,42% 3,71% 479.900
03/01/2017 34,82 34,84 33,48 33,72 -1,69% 3,91% 344.200
30/12/2016 34,66 34,86 34,09 34,30 -0,87% 2,22% 361.700
29/12/2016 35,12 35,49 34,32 34,60 -1,37% 3,33% 330.000
28/12/2016 35,49 36,00 35,01 35,08 -0,96% 2,79% 326.200
27/12/2016 35,60 35,83 34,28 35,42 +1,23% 4,35% 479.900
23/12/2016 33,94 35,12 33,91 34,99 +3,12% 3,57% 425.900
22/12/2016 33,77 34,18 33,22 33,93 +0,44% 2,84% 313.400
21/12/2016 34,27 34,49 33,52 33,78 -1,20% 2,83% 265.800
20/12/2016 34,17 34,45 33,74 34,19 +0,21% 2,08% 219.800
19/12/2016 34,11 34,35 34,03 34,12 +0,35% 0,94% 374.700
16/12/2016 34,20 34,50 33,23 34,00 -0,06% 3,71% 771.500
15/12/2016 33,73 34,23 33,43 34,02 +0,62% 2,37% 347.800
14/12/2016 34,23 34,45 33,16 33,81 -0,85% 3,77% 461.900
13/12/2016 32,90 34,34 32,90 34,10 +3,30% 4,38% 1.137.700
12/12/2016 32,82 33,13 32,09 33,01 -0,42% 3,17% 401.700
09/12/2016 33,59 34,01 32,78 33,15 -1,22% 3,66% 486.200
08/12/2016 34,14 34,14 33,05 33,56 -2,07% 3,19% 584.200
07/12/2016 32,76 34,68 32,63 34,27 +3,88% 6,27% 522.600